U.S. Sen. Bernie Sanders on Monday called for an inspector general investigation into an effort to grant a company tied to an ex-government employee an exclusive patent license for a cancer treatment produced with public resources, as revealed last week by The American Prospect.Sanders , who chairs the Senate Health, Education, Labor, and Pensions Committee, demanded a probe of the National Institutes of Health patent proposal in a letter to Christi Grimm, inspector general of the U.S.
While Love presumes that Hinrichs is either the creator of Scarlet TCR or one of its principal executives, the NIH would not confirm Hinrichs' role to Love, and offered essentially no information about the company. The Prospect attempted to contact the NIH about Scarlet TCR and Hinrichs as well, and did not receive a response. Hinrichs also did not respond to a request for comment.